Captisol technology
WebKansas Higuchi Biosciences Center .The technology of Captisol is used to address the limitations of drugs currently on the market. Captisol-enabled, FDA-approved drugs are sold by Pfizer, Bristol-Myers Squibb, and Baxter International. ... Captisol is an excipient used to improve solubility in certain medication injectable products, Captisol is ... WebJun 1, 2024 · "In 2001, I was fortunate to join a team of scientists and business entrepreneurs, many of whom are KU graduates, to develop and commercialize the nascent Captisol technology," said James Pipkin ...
Captisol technology
Did you know?
WebRemdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. During the COVID‑19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 in numerous countries.. Remdesivir was originally … WebJun 1, 2024 · The Captisol platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs.
WebJan 5, 2009 · CyDex Pharmaceuticals Announces CAPTISOL® Technology Used in Recently Approved Cosolvent-Free Formulation of Amiodarone IV NEXTERONE® Developed by Prism Pharmaceuticals is First CyDex Licensed... WebOct 23, 2024 · The Captisol platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. The Pfenex Expression ...
WebCaptisol was invented and initially developed by scientists at the University of Kansas' Higuchi Biosciences Center for specific use in drug development and formulation. This unique technology has enabled six FDA-approved products, including Onyx Pharmaceuticals' Kyprolis(TM), Pfizer's Vfend(R)IV and Baxter International's Nexterone(R). WebNot all cyclodextrins are created equal. Captisol ® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly …
WebFeb 3, 2024 · The Captisol ® platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs.
WebA: Captisol is a unique reproducible mixture of polyanionic β-cyclodextrin derivatives in which a sodium sulfonate salt is tethered to the lipophilic cyclodextrin cavity by a butyl ether group, or sulfobutylether (SBE). differences between subjective and objectiveWebNOTIFICATION SOLUTIONS. UL Listed and Code Compliant solutions help assure your system will operate when needed. Being UL Listed for Private and Public mode … format hfs to ntfsWebMar 31, 2013 · Any transfer of CyDex’s Captisol manufacturing technology (which shall not include technology which is proprietary to the Third Party Manufacturer or Pfizer) to Spectrum or its Contract Manufacturer shall be subject to contractual covenants reasonably satisfactory to CyDex regarding confidentiality, limitations on use and non-competition. ... differences between streaming servicesWebJan 14, 2011 · In the event that a product involving the Company Technology is sold as a single product, component, or service, or in the event that the sale is of a pharmaceutical product that is enhanced or enabled by integration with the Captisol technology, then Revenue shall include 100% of the revenues or other assets received from such sale or … format hhWebOct 23, 2024 · Ligand maintains a broad global patent portfolio for Captisol with more than 400 issued patents worldwide relating to the technology (including 37 in the U.S.) and … differences between strategy and tacticsWebThe Captisol® technology is used to address the limitations of currently marketed drugs. Eight FDA-approved, Captisol-enabled® medications are marketed by: Pfizer, Bristol-Myers Squibb and Baxter International. … differences between string and nsstringWebIndustry Recognized Captisol Technology Brand - Captisol is recognized in the pharmaceutical industry as a powerful answer to the solubility challenges frequently faced by drug-development companies. CyDex' success is primarily based on solving drug formulation problems, particularly in the area of IV and topical formulations. format hhmm or hmm